Overview of rHGH therapy
January 14, 2015- Interviewed by Steven E. Greer, MD
We interviewed Dr. Shlomo Melmed, Director of the Clinical Research Institute and Dean of Faculty at Cedars Sinai Medical center in Los Angeles, about recombinant Human Growth Hormone (rHGH) therapies. Dr. Melmed writes the chapter on pituitary for Harrison’s Internal Medicine textbook, among other accomplishments.
We asked him whether exogenous HGH or IGF-1 causes cancer? Do they cause acromegaly? What is the federal law that is unique to HGH prescribing?
Cedars Sinai LA, Diabetes, Endocrinology, FDA, Gastroenterology/Hepatology, Internal medicine, Neurology, OBGYN, Oncology, Pediatrics, Policy, Preventive Medicine | apples49 | 
March 19, 2015 4:24 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
